EIR Par Pharmaceuticals Feb 2005

Caryn Mcnab FDA, Binh Nguyen FDA$595.00 - Available Now

FDA investigators audited the Par Pharmaceuticals - Irvine, CA, United States facility and issued inspectional observation (via FDA 483) on 03 Feb 2005.

Product details

  • Category:
  • Inspection end: 03 Feb 2005
  • Location: Irvine, United States
  • FEI: 3004492248
Add To Cart